ClinicalTrials.gg
Drug

Elifibranor clinical trials

Also written GFT505, Elafibranor and IPN60190.

studies test it
23
open now
2
in phase 3
6
first study started
2009

How each study uses elifibranor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the elifibranor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Jun 2024 · IQIRVO · NDA 218860 (FDA, Drugs@FDA)
European Union
19 Sept 2024 · Iqirvo · EMEA/H/C/006231 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

GFT505 80mg
5

Brand

Iqirvo®
1

Development codes

GFT505
12
IPN60190
3

Other names

Elafibranor
11
Elafibranor 80mg
2
Elafibranor 80 mg
2
Elafibranor 120 mg
2
Elafibranor 120mg
2

Studies by the year they started

23 studies that test it; most in 2019 (5)

Studies that test elifibranor, by start year
YearStudies
20092
20101
20112
20121
20141
20161
20171
20181
20195
20201
20223
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
9
Phase 3
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 0

Genfit (15) · Ipsen (8)

Often tested with

Tested in the same studies.

Indomethacin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test elifibranor, phase 3 first.

Studies

Open first, then newest update. How each study uses elifibranor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test elifibranor →

Codes

What other systems call elifibranor · ClinicalTrials.gg INT006416

  • MeSH (NLM) C585906elifibranorConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2J3H5C81A5ELAFIBRANORConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.